Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate 00480-3685
Product NDC
00480-3685- Manufacturer
- Teva Pharmaceuticals, Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- October 10, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA210876
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Aspartate Monohydrate | 9.375 mg/1 |
| Amphetamine Sulfate | 9.375 mg/1 |
| Dextroamphetamine Saccharate | 9.375 mg/1 |
| Dextroamphetamine Sulfate | 9.375 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]
Packaging Options(1)
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0480-3685-01)